+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Human Insulin"

From
Human Insulin - Global Strategic Business Report - Product Thumbnail Image

Human Insulin - Global Strategic Business Report

  • Report
  • March 2025
  • 94 Pages
  • Global
From
human insulin market - Forecasts from 2025 to 2030 - Product Thumbnail Image

human insulin market - Forecasts from 2025 to 2030

  • Report
  • December 2024
  • 144 Pages
  • Global
From
Insulin Drugs Market Report 2025 - Product Thumbnail Image

Insulin Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
From
Insulin Market 2024-2028 - Product Thumbnail Image

Insulin Market 2024-2028

  • Report
  • August 2024
  • 161 Pages
  • Global
From
From
Global Markets for Insulin Drug and Delivery Technologies - Product Thumbnail Image

Global Markets for Insulin Drug and Delivery Technologies

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Loading Indicator

The Human Insulin market is a segment of the Endocrine and Metabolic Disorders Drugs market. It is composed of drugs used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use the insulin it produces. Human Insulin is a synthetic form of insulin, which is produced in a laboratory and is identical to the insulin produced by the human body. It is used to treat both type 1 and type 2 diabetes. Human Insulin is available in a variety of forms, including short-acting, intermediate-acting, and long-acting. It is typically administered via injection or an insulin pump. Some companies in the Human Insulin market include Novo Nordisk, Sanofi, Eli Lilly, and Biocon. Show Less Read more